These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 9347948
1. Cholecystokinin (CCK-8) modulates vesicular release of excitatory amino acids in rat hippocampal nerve endings. Breukel AI, Lopes da Silva FH, Ghijsen WE. Neurosci Lett; 1997 Sep 26; 234(1):67-70. PubMed ID: 9347948 [Abstract] [Full Text] [Related]
2. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons. Lanza M, Makovec F. Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan 26; 361(1):33-8. PubMed ID: 10651144 [Abstract] [Full Text] [Related]
3. Cholecystokinin-GABA interactions in rodent cortex: analyses of cholecystokinin effects on K(+)- and L-glutamate-induced release of [3H]GABA from rat cortical slices and cultured mouse cortical neurones. Hickling YM, Cheung NS, Larm JA, Cowen MS, Shulkes A, Beart PM. Neurochem Int; 1997 Feb 26; 30(2):171-9. PubMed ID: 9017664 [Abstract] [Full Text] [Related]
4. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes. You ZB, Godukhin O, Goiny M, Nylander I, Ungerstedt U, Terenius L, Hökfelt T, Herrera-Marschitz M. Naunyn Schmiedebergs Arch Pharmacol; 1997 May 26; 355(5):576-81. PubMed ID: 9151295 [Abstract] [Full Text] [Related]
5. Presynaptic modulation of cholecystokinin release by protein kinase C in the rat hippocampus. Breukel AI, Wiegant VM, Lopes da Silva FH, Ghijsen WE. J Neurochem; 1998 Jan 26; 70(1):341-8. PubMed ID: 9422380 [Abstract] [Full Text] [Related]
6. Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices. Migaud M, Roques BP, Durieux C. Neuropharmacology; 1994 Jun 26; 33(6):737-43. PubMed ID: 7936111 [Abstract] [Full Text] [Related]
7. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain. Ge J, Long SK, Kilpatrick IC. Eur J Pharmacol; 1998 Mar 19; 345(2):163-70. PubMed ID: 9600632 [Abstract] [Full Text] [Related]
8. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat. Gronier B, Debonnel G. Synapse; 1995 Oct 19; 21(2):158-68. PubMed ID: 8584977 [Abstract] [Full Text] [Related]
9. Cholecystokinin excites neostriatal neurons in rats via CCKA or CCKB receptors. Davidowa H, Albrecht D, Gabriel HJ, Heublein S, Wetzel K. Eur J Neurosci; 1995 Dec 01; 7(12):2364-9. PubMed ID: 8845940 [Abstract] [Full Text] [Related]
10. Administration of cholecystokinin sulphated octapeptide (CCK-8S) induces changes on rat amino acid tissue levels and on a behavioral test for anxiety. Acosta GB. Gen Pharmacol; 1998 Oct 01; 31(4):637-41. PubMed ID: 9792229 [Abstract] [Full Text] [Related]
11. Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release. Pérez de la Mora M, Hernández-Gómez AM, Arizmendi-García Y, Jacobsen KX, Lara-García D, Flores-Gracia C, Crespo-Ramírez M, Gallegos-Cari A, Nuche-Bricaire A, Fuxe K. Eur J Neurosci; 2007 Dec 01; 26(12):3614-30. PubMed ID: 18088282 [Abstract] [Full Text] [Related]
12. Effects of uptake carrier blockers SK & F 89976-A and L-trans-PDC on in vivo release of amino acids in rat hippocampus. Zuiderwijk M, Veenstra E, Lopes da Silva FH, Ghijsen WE. Eur J Pharmacol; 1996 Jul 04; 307(3):275-82. PubMed ID: 8836615 [Abstract] [Full Text] [Related]
13. Arachidonic acid inhibits uptake of amino acids and potentiates PKC effects on glutamate, but not GABA, exocytosis in isolated hippocampal nerve terminals. Breukel AI, Besselsen E, Lopes da Silva FH, Ghijsen WE. Brain Res; 1997 Oct 31; 773(1-2):90-7. PubMed ID: 9409709 [Abstract] [Full Text] [Related]
14. gamma-Aminobutyric acid (GABA) stimulates somatostatin release following activation of a GABA uptake carrier located on somatostatin nerve endings of rat cerebral cortex. Raiteri M, Bonanno G, Fedele E, Fontana G, Gemignani A. J Pharmacol Exp Ther; 1991 Jan 31; 256(1):88-93. PubMed ID: 1671101 [Abstract] [Full Text] [Related]
15. Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro. Kombian SB, Ananthalakshmi KV, Parvathy SS, Matowe WC. J Physiol; 2004 Feb 15; 555(Pt 1):71-84. PubMed ID: 14673185 [Abstract] [Full Text] [Related]
16. GABA enhances acetylcholine release from hippocampal nerve endings through a mechanism blocked by a GABA uptake inhibitor. Bonanno G, Raiteri M. Neurosci Lett; 1986 Oct 20; 70(3):360-3. PubMed ID: 3022197 [Abstract] [Full Text] [Related]
17. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus. Luccini E, Musante V, Neri E, Raiteri M, Pittaluga A. J Neurosci Res; 2007 Dec 20; 85(16):3657-65. PubMed ID: 17671992 [Abstract] [Full Text] [Related]
18. Cholecystokinin-GABA interactions in rat striatum. Rakovska A. Neuropeptides; 1995 Nov 20; 29(5):257-62. PubMed ID: 8587661 [Abstract] [Full Text] [Related]
19. Cholecystokinin activates CCKB-receptor-mediated Ca-signaling in hippocampal astrocytes. Müller W, Heinemann U, Berlin K. J Neurophysiol; 1997 Oct 20; 78(4):1997-2001. PubMed ID: 9325368 [Abstract] [Full Text] [Related]
20. Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices. Ferraro L, Beani L, Trist D, Reggiani A, Bianchi C. J Neurochem; 1999 Nov 20; 73(5):1973-81. PubMed ID: 10537055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]